Clinical Trials Browser

Phase 2 × Becaplermin × 90 days × Clear all

NCT06634030 2026-03-23

Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction

Phase 2 Recruiting

Surgical Wound